Table 3.
Adjusted incidence risk ratios and 95% CIs for primary and mental health Veterans Affairs (VA) video care use within 6 months of tablet receipt among veterans who received their tablets before or during the COVID-19 pandemic.
| Characteristics | Model 1: prepandemic cohorta (n=6784), risk ratio (95% CI) | Model 2: pandemic cohortb (n=36,107), risk ratio (95% CI) | |
| Age group (years) | |||
|
|
18-44 | 1.00 | 1.00 |
|
|
45-64 | 0.97 (0.88-1.07) | 0.91 (0.87-0.96) |
|
|
65+ | 0.82 (0.73-0.92) | 0.83 (0.79-0.87) |
| Race | |||
|
|
American Indian or Alaska Native | 1.01 (0.77-1.33) | 0.96 (0.85-1.08) |
|
|
Asian | 1.20 (0.80-1.79) | 0.97 (0.82-1.14) |
|
|
Black or African American | 0.94 (0.85-1.04) | 0.99 (0.96-1.00) |
|
|
Native Hawaiian or Pacific Islander | 1.05 (0.75-1.48) | 0.97 (0.85-1.11) |
|
|
Unknown | 0.99 (0.83-1.19) | 0.98 (0.91-1.05) |
|
|
White | 1.00 | 1.00 |
| Ethnicity | |||
|
|
Not Hispanic/Latino | 1.00 | 1.00 |
|
|
Hispanic/Latino | 0.95 (0.82-1.11) | 1.01 (0.94-1.07) |
|
|
Unknown | 1.03 (0.82-1.29) | 1.00 (0.92-1.10) |
| Gender | |||
|
|
Male | 1.00 | 1.00 |
|
|
Female | 1.04 (0.95-1.14) | 1.04 (1.00-1.08) |
| Rurality | |||
|
|
Urban | 1.00 | 1.00 |
|
|
Rural | 1.13 (1.04-1.22) | 1.00 (0.97-1.03) |
|
|
Highly rural | 1.13 (0.95-1.33) | 1.00 (0.92-1.08) |
| History of housing instability | |||
|
|
No | 1.00 | 1.00 |
|
|
Yes | 0.81 (0.72-0.91) | 0.92 (0.88-0.95) |
| Number of chronic conditions | |||
|
|
0-3 | 1.00 | 1.00 |
|
|
4-6 | 1.01 (0.90-1.14) | 0.99 (0.94-1.04) |
|
|
7-9 | 0.98 (0.86-1.12) | 1.00 (0.95-1.05) |
|
|
10+ | 0.94 (0.80-1.10) | 1.00 (0.94-1.06) |
| Any mental health condition(s) | |||
|
|
No | 1.00 | 1.00 |
|
|
Yes | 1.34 (1.14-1.57) | 1.12 (1.06-1.18) |
| VAc priority enrollment group | |||
|
|
No special enrollment | 1.00 | 1.00 |
|
|
Low income | 1.02 (0.85-1.23) | 0.96 (0.90-1.02) |
|
|
Low or moderate disability | 1.04 (0.86-1.25) | 0.98 (0.92-1.05) |
|
|
High disability | 1.13 (0.96-1.34) | 1.03 (0.97-1.09) |
aPrepandemic cohort comprises all veterans who received tablets between March 11, 2019, and September 10, 2019; these veterans used their tablets for a maximum of 6 months after receiving their tablets, with all included use occurring on or before March 10, 2020.
bPandemic cohort comprises all veterans who received tablets between March 11, 2020, and September10, 2020; these veterans used their tablets for a maximum of 6 months after receiving their tablets, with all included use occurring on or before March 10, 2021.
cVA: Veterans Affairs.